These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1735613)

  • 1. Interleukin-1 produced by tumorigenic fibroblasts influences tumor rejection.
    Zöller M; Douvdevani A; Segal S; Apte RN
    Int J Cancer; 1992 Feb; 50(3):443-9. PubMed ID: 1735613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 production by transformed fibroblasts. II. Influence on antigen presentation and T-cell-mediated anti-tumor response.
    Zöller M; Douvdevani A; Segal S; Apte RN
    Int J Cancer; 1992 Feb; 50(3):450-7. PubMed ID: 1531210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 and pro-inflammatory cytokines produced by primary and transformed fibroblasts abrogate the tumorigenic potential of fibrosarcomas.
    Apte RN; Douvdevani A; Huleihel M; Fima E; Hacham M; Shimoni N; Dvorkin T; Segal S
    Folia Biol (Praha); 1992; 38(3-4):240-57. PubMed ID: 1426419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer.
    Douvdevani A; Huleihel M; Zöller M; Segal S; Apte RN
    Int J Cancer; 1992 Jul; 51(5):822-30. PubMed ID: 1612788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
    Wilhelm SA; Mukherji B
    J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS; Lala PK
    J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
    Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Huleihel M; Fima E; Hacham M; Voronov E
    Folia Biol (Praha); 1994; 40(1-2):1-18. PubMed ID: 7958060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejection.
    Hara I; Nguyen H; Takechi Y; Gansbacher B; Chapman PB; Houghton AN
    Int J Cancer; 1995 Apr; 61(2):253-60. PubMed ID: 7705956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenicity and lysis by natural killers.
    Collins JL; Patek PQ; Cohn M
    J Exp Med; 1981 Jan; 153(1):89-106. PubMed ID: 6161207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cytokine production by fibroblasts-implications for normal connective tissue homeostasis and pathological conditions.
    Apte RN
    Folia Microbiol (Praha); 1995; 40(4):392-404. PubMed ID: 8763153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement.
    Di Carlo E; Comes A; Basso S; De Ambrosis A; Meazza R; Musiani P; Moelling K; Albini A; Ferrini S
    J Immunol; 2000 Sep; 165(6):3111-8. PubMed ID: 10975824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
    Douvdevani A; Huleihel M; Segal S; Apte RN
    Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular tumorigenicity in nude mice. Role of susceptibility to natural killer cells.
    Klein AS; Plata F; Jackson MJ; Shin S
    Exp Cell Biol; 1979; 47(6):430-45. PubMed ID: 520649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW; Trimble WS; Hozumi N; Roder JC
    J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma-independent autocrine cytokine regulatory mechanism in reprogramming of macrophage responses to bacterial lipopolysaccharide.
    Brewington R; Chatterji M; Zoubine M; Miranda RN; Norimatsu M; Shnyra A
    J Immunol; 2001 Jul; 167(1):392-8. PubMed ID: 11418675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
    Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
    J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicity.
    Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Fima E; Hacham M; Huleihel M; Benharroch D
    Immunol Lett; 1993 Dec; 39(1):45-52. PubMed ID: 8144190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
    Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
    J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.